Raymond Alsko
Director, Sales & Key Accounts
Wavelength Pharmaceuticals
About me
Primary Company Activity
Custom Manufacturing/ Custom Synthesis
Department
Sales
Position
VP / Director
Purchasing Responsibility
I have no purchasing responsibility
Attendee Access Type
Online Only
Offering:
Offering: Markets Active in
CanadaUnited States of America
Interested:
Interested in: Business Activity
Pharmaceutical Company (innovator finished products)
Interested in: Company/Product Certifications
FDAGMP
Interested in: Products or Services
Finished Dosage Forms
Geographical areas you plan to expand to:
CanadaUnited States of America
Interested in: Finished Dosage
AerosolsCapsulesCreams,Lotions,OintmentsDropsFilmsGel capsHomeopathicsInjectablesOtherParenteralsPowdersSoft tabsSpraysSuppositoriesSuspensionsSyrupsTabletsTransdermal patches
Interested in: Pharmaceutical products / ATC coding
Not Interested in Pharmaceutical products / ATC coding
Contact details
Is member of
Wavelength Pharmaceuticals
Wavelength Enterprises Ltd.
is attending
How will the New Administration Impact the US Pharma Market?
Manufacturing Innovation: The Case for Continuous Manufacturing
The Future of the Generics Landscape: Key Branded Drugs Losing Exclusivity in 2021 and Beyond
Nicole Reynolds · Clarivate
API Manufacturing - Trend Outlook
Gianluca Franguelli · EDMOND PHARMA S.R.L.
Molly Bowman · Clarivate
Ishaan Malik · Piramal Pharma Solutions
Podcast Episode 3: Spray Drying - Formulation Approaches and Technologies
Stefano Console · Oriento SA